TY  - JOUR
T1  - Department of Error : [Erratum zu: Cuzick J, Sestak I, Forbes JF, et al. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial. Lancet 2020; 395: 117–22]
T2  - The lancet
N2  - The Acknowledgments of this Article have been updated as of Feb 13, 2020.
Y1  - 2020
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/53140
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-531402
SN  - 1474-547X
SN  - 0140-6736
N1  - Copyright: © 2020 The Author(s). Published by Elsevier Ltd. User License: Creative Commons Attribution (CC BY 4.0)
N1  - Ursprünglicher Artikel erschienen in: The lancet, 395.2020, Nr. 10218, S. 117-122, doi:10.1016/S0140-6736(19)32955-1
VL  - 395
IS  - 10233
SP  - 496
EP  - 496
PB  - Elsevier
CY  - London [u. a.]
ER  -